Issued by Department of Health
18 February 2002
We have every confidence that Gauteng is basing its expansion of the Nevirapine programme on its experiences in the research sites that were launched in the province from May 2001. More than 17 000 mothers have been seen at the existing Gauteng sites, all of which are run within the national protocols and offer a comprehensive service. Gauteng has also had the benefit of information from other research sites across the counting.
Furthermore, Gauteng has historically strong health services and a substantial HIV/AIDS budget. The Gauteng Health Department is therefore in a position to advance the programme within the parameters set by the Health Minmec.
Dr Ayanda Ntsaluba
Director-General of Health
Queries to Jo-Anne Collinge at 082 787 0202